Glucagon-like peptide-1 improves β-cell dysfunction by suppressing the miR-27a-induced downregulation of ATP-binding cassette transporter A1 - 15/12/17
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 6 |
| Iconographies | 4 |
| Vidéos | 0 |
| Autres | 0 |
Abstract |
Lipotoxicity is considered one of the main causes of deterioration in β-cells function. Glucagon-like peptide-1 (GLP-1) has been revealed to protect and improve pancreatic β-cell function against lipotoxicity. However, the mechanism behind these is largely unknown. The aim of this study was to investigate the effects of GLP-1 on cholesterol-induced lipotoxicity in INS-1 cells and examine the underlying mechanisms. The cell viability was determined, and caspase-3 was used to assess the effects of GLP-1 on cholesterol-induced apoptosis. The alterations of miR-27a and ABCA1 resulting from incubation with cholesterol or GLP-1 were detected by real-time PCR and western blot. The inhibition and overexpression of miR-27a were established to explore the effects of a GLP-1-mediated decrease in miR-27a. Further, Oil red O staining and cholesterol measurement were used to detect lipid accumulation. The β-cells function was measured in glucose-stimulated insulin secretion. Our data shows that cholesterol significantly attenuated cell viability, promoted cell apoptosis, facilitated lipid accumulation, and impaired β-cells function, and these effects were significantly reversed by GLP-1. Furthermore, the results demonstrated that GLP-1 decreased miR-27a expression and increased the expression of ABCA1. In conclusion, GLP-1 may affect cholesterol accumulation and β-cells dysfunction by regulating the expression of miR-27a and ABCA1.
Le texte complet de cet article est disponible en PDF.Keywords : Glucagon-like peptide-1, Cholesterol, ATP-binding cassette transporter A1, miR-27a, β-cell dysfunction
Plan
Vol 96
P. 497-502 - décembre 2017 Retour au numéro
Article précédent
- Long-term treatment with chaethomellic acid A reduces glomerulosclerosis and arteriolosclerosis in a rat model of chronic kidney disease
- António Nogueira, Helena Vala, Carmen Vasconcelos-Nóbrega, Ana Isabel Faustino-Rocha, Carlos André Pires, Aura Colaço, Paula Alexandra Oliveira, Maria João Pires
- Anti-hypersensitivity effects of the phthalimide derivative N-(4methyl-phenyl)-4-methylphthalimide in different pain models in mice
- Gislaine Francieli da Silva, Mariana Ferreira dos Anjos, Lilian Wunsch Rocha, Luiz Felipe Gomes Rebello Ferreira, Dorimar Serafim Stiz, Rogério Corrêa, Jose Roberto Santin, Valdir Cechinel Filho, Marcelo Zaldini Hernandes, Nara Lins Meira Quintão
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?